SANTA CLARA
From health care reform implications to collaboration accounting to valuing R&D, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, PwC, Hogan Lovells, life science analysts and your industry counterparts.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $795 (save $200 off the regular price of $995 if you register by April 1st).
This year’s event will be held at the Hilton Santa Clara.
We have a block of rooms available at $379 per night.
Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110
3. Email your contact info to be invoiced to mtarman@acslive.com
*Agenda will be updated to reflect latest industry issues in early 2020.
| Agenda: DAY 1 | ||
|---|---|---|
| 8:00 | 8:45 | Continental Breakfast and Registration |
| 8:45 | 10:10 | Collaboration Accounting and Revenue Recognition Update Interaction of 808 and 606 Evaluating “active participation” Measure of progress Options to purchase licenses Options to purchase equity Other SEC comment letter themes ASC 606 Implementation Issues and Examples Working through the five step model Implementation issues and lessons learned in the life science industry |
| 10:10 | 10:25 | Break |
| 10:25 | 12:00 | Gross to Net (GTN) Understanding the Complexities Internal and External Challenges Elements leading to GTN model creation Industry examples |
| 12:00 | 1:00 | Lunch |
| 1:00 | 2:00 | Legal Update: IPO Trends Unicorns and timing give IPOs a lift Geopolitical and trade issues Outlook |
| 2:00 | 2:05 | Break |
| 2:05 | 3:15 | Business Combinations In-License Agreements Asset Acquisitions vs. Business Combination Considerations Industry trends |
| 3:15 | 3:20 | Break |
| 3:20 | 4:20 | Product Launch Considerations Related to US Government Pricing |
| 4:20 | 4:25 | Break |
| 4:25 | 5:30 | Tax Update R&D Tax Credits Tax Accounting Methods Orphan Drug Credit |
| Agenda: DAY 2 | ||
|---|---|---|
| 8:15 | 8:45 | Continental Breakfast |
| 8:45 | 10:15 | SEC & PCAOB Update Comment letter themes MD&A Update Changing regulatory environment Non-GAAP measures ICFR Material weaknesses Cybersecurity disclosures |
| 10:15 | 10:25 | Break |
| 10:25 | 12:00 | Accounting for Leases Overview of New Rules Identifying a Lease Contract Components Lease Classification Recognition and Measurement Ongoing Requirements Practical Expedients Examples |
| 12:00 | 1:00 | Lunch |
| 1:00 | 2:30 | Valuation Update Fair Value Accounting Industry Standars for Valuation Models Valuing IPR&D Projects Valuation and Impairment of Intangible Assets |
| 2:30 | 2:45 | Break |
| 2:45 | 4:15 | Fraud & Cybersecurity in Life Science Recent Trends Cases and examples Cybersecurity |
| Conference Series Speakers Include: |
|---|
| Nathan Mitchell Deloitte & Touche, Partner |
| Dan Coleman Ernst & Young, Partner |
| Kevin Jackson PwC, Director |
| David Nadell Duff & Phelps, Director - Life Science Industry |
| Brianne Loyd Deloitte & Touche, Senior Manager - National Office Consultation |
| Nick Lubold Deloitte & Touche, Manager |
| Vibhor Chandra Deloitte & Touche, Senior Manager |
| Brian Cuneo Latham & Watkins, Partner |
| Shayne Kennedy Latham & Watkins, Partner |
| May Yu Deloitte & Touche, Senior Manager -National Office Consultation |
| Andrew Trivella Deloitte & Touche, Senior Manager |
| PJ Theisen Deloitte & Touche, Senior Manager |
| Jenny Chan Deloitte & Touche, Partner |
| Kevin Dueck Deloitte & Touche, Partner |
| Matt Walton Deloitte & Touche, Partner |
| Kaetlin Liverman Deloitte & Touche, Manager |
| Jonathan Margate Deloitte & Touche, Partner |